Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.54 |
| ▸ | ST14 | Q9Y5Y6 | 3/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | INPPL1 | O15357 | 4/20 | 0.48 |
| ▸ | INPP5A | Q14642 | 3/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ABAT | P80404 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.42 |
| ▸ | ANPEP | P15144 | 1/20 | 0.42 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | INPP5B | P32019 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27339665 | 0.98 | SRC (0.52) | SRCST14BLMCA1CA2 | |
| SCHEMBL28106181 | 0.85 | ST14 (0.46) | SRCST14BLMCA1CA2 | |
| SCHEMBL28031670 | 0.84 | CYP2C19 (0.68) | ST14BLMCYP2C19SMN1; SMN2ABAT | |
| SCHEMBL6431657 | 0.84 | TAAR1 (0.52) | SRCBLMCA1CA2INPPL1 | |
| SCHEMBL329313 | 0.82 | SRC (0.75) | SRCBLMCA1CA2INPPL1 | |
| SCHEMBL27826220 | 0.81 | SRC (0.53) | SRCST14INPPL1INPP5AANPEP | |
| SCHEMBL27938230 | 0.81 | SRC (0.52) | SRCST14CYP2C19SMN1; SMN2ANPEP | |
| SCHEMBL4957575 | 0.81 | SRC (0.56) | SRCBLMCA1CA2INPPL1 | |
| SCHEMBL3123300 | 0.80 | SLC6A4 (0.58) | BLMANPEP | |
| SCHEMBL21807707 | 0.80 | SLC6A4 (0.58) | BLMANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103146152-A | Flame retardant copolyether ester composition and product comprising same | DU PONT | 2013-06-12 | — | — | CN | claimed |
| CN-103146153-A | Flame-retardant copolyether ester composition and product comprising the flame-retardant copolyether ester composition | DU PONT | 2013-06-12 | — | — | CN | claimed |
| US-11040048-B2 | Medicament for treating influenza characterized by combining a Cap-dependent endonuclease inhibitor and an anti-influenza drug | SHIONOGI & CO., LTD. (JP) | 2021-06-22 | — | — | US | disclosed |
| US-20200261481-A1 | A MEDICAMENT FOR TREATING INFLUENZA CHARACTERIZED BY COMBINING A CAP-DEPENDENT ENDONUCLEASE INHIBITOR AND AN ANTI-INFLUENZA DRUG | SHIONOGI & CO., LTD. (JP) | 2020-08-20 | — | — | US | disclosed |
| CN-107107049-A | Selective hydrogenation catalyst and its preparation and application | 切弗朗菲利浦化学公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-102341175-B | Selective hydrogenation catalyst and preparation and application thereof | Chevron Phillips Chemical Co.,L.P. (US) | 2016-11-30 | — | — | CN | disclosed |
| CN-103635497-A | Method for polymerizing resin casting for use as epoxy acrylic optical lens and resin composition containing internal releasing agent for use in epoxy acrylic optical lens | KOC SOLUTION CO LTD | 2014-03-12 | — | — | CN | disclosed |
| CN-103635520-A | Resin composition and molded article | FUJIFILM CORP | 2014-03-12 | — | — | CN | disclosed |
| CN-103146152-A | Flame retardant copolyether ester composition and product comprising same | DU PONT | 2013-06-12 | — | — | CN | disclosed |
| CN-103146153-A | Flame-retardant copolyether ester composition and product comprising the flame-retardant copolyether ester composition | DU PONT | 2013-06-12 | — | — | CN | disclosed |
| CN-102341175-A | Selective hydrogenation catalyst and methods of making and using same | CHEVRON PHILLIPS CHEMICAL CO | 2012-02-01 | — | — | CN | disclosed |
| CN-100384917-C | Electrically conductive thermoplastic polymer composition | DOW GLOBAL TECHNOLOGIES INC (US) | 2008-04-30 | — | — | CN | disclosed |
| CN-100335511-C | Vinyl homopolymer or method for producing vinyl and C3-C20 alpha-olefine randompolymer | MITSUI CHEMICALS INC (JP) | 2007-09-05 | — | — | CN | disclosed |
| CN-1897810-A | Corrosion inhibitors for aqueous pesticide formulations | SYNGENTA PARTICIPATIONS AG (CH) | 2007-01-17 | — | — | CN | disclosed |
| CN-1781954-A | Vinyl homopolymer or method for producing vinyl and c3-c20 alpha-olefine randompolymer | MITSUI CHEMICALS INC (JP) | 2006-06-07 | — | — | CN | disclosed |
| CN-1761706-A | Electrically conductive thermoplastic polymer composition | DOW GLOBAL TECHNOLOGIES INC (US) | 2006-04-19 | — | — | CN | disclosed |
| CN-1748001-A | Halogen free ignition resistant thermoplastic resin compositions | DOW GLOBAL TECHNOLOGIES INC (US) | 2006-03-15 | — | — | CN | disclosed |
| CN-1229399-C | Ethylene polymer, process for producing the same, and molded article using the same | MITSUI CHEMICALS INC (JP) | 2005-11-30 | — | — | CN | disclosed |
| CN-1659217-A | Halogen-free flame-retardant thermoplastic resin composition | DOW GLOBAL TECHNOLOGIES INC (US) | 2005-08-24 | — | — | CN | disclosed |
| CN-1386768-A | Ethylene polymer, process for producing the same, and molded article using the same | MITSUI CHEMICALS INC (JP) | 2002-12-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200261481-A1 | A MEDICAMENT FOR TREATING INFLUENZA CHARACTERIZED BY COMBINING A CAP-DEPENDENT ENDONUCLEASE INHIBITOR AND AN ANTI-INFLUENZA DRUG | RNASEH1, RNASEL, RNPEP | SRC 3543/4885ST14 2320/4885BLM 3040/4885 |
| US-11040048-B2 | Medicament for treating influenza characterized by combining a Cap-dependent endonuclease inhibitor and an anti-influenza drug | RNASEH1, RNPEP, RNASEL | SRC 3348/4885ST14 2512/4885BLM 3011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.